跳至主要内容
临床试验/NCT02349893
NCT02349893已完成不适用

Radiofrequency Ablation for Multi-level Obstructive Sleep Apnea: A Single-arm, Multicenter Study

Olympus Surgical Technologies Europe11 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2015年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
56
试验地点
11
主要终点
Mean Apnea Hypopnea Index (AHI) at 6 Months Post-baseline

研究概览

简要总结

The United States is currently experiencing an increase in the incidence and prevalence of obstructive sleep apnea (OSA). With prevalence in middle-aged adults of 2 to 4% of the population, untreated OSA has been implicated in increased risk for cardiovascular disease, including hypertension and heart failure, daytime sleepiness, and increased risk of motor vehicle accidents.

This study was design in order to evaluate the CelonProSleep plus for multi-level radiofrequency ablation (RFA) of the palate and base of tongue as a treatment for mild to moderate obstructive sleep apnea syndrome (OSAS).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (≥ 22 years)
  • Self-report of daytime somnolence
  • Body mass index (BMI) ≤ 32
  • Mild to moderate obstructive sleep apnea (AHI 10 - 30; lowest O2 sat ≥ 80%)
  • Evidence of palate and tongue base collapse on supine fiberoptic examination
  • Non-compliant with or refusal of continuous positive airway pressure therapy (CPAP) (< 4 hours per night by patient report)
  • No prior surgical treatment for OSAS other than nasal surgery
  • Willing and capable of providing informed consent

排除标准

  • Another significant sleep disorder (e.g., insomnia, periodic limb movement)
  • Tonsillar hypertrophy
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Interstitial Lung Disease (ILD)
  • Cystic Fibrosis
  • Acute Repiratory Distress Syndrome (ARDS)
  • Nasal or supraglottic obstruction on fiberoptic examination
  • American Society of Anesthesiologists (ASA) class III ,IV, V
  • Latex allergy
  • Lidocaine allergy
  • Pregnancy or plans to become pregnant Note: women of childbearing potential must demonstrate a negative pregnancy test upon enrollment; those patients qualified to progress to RFA must also demonstrate a negative pregnancy test within 7 days prior to the date of RFA procedure.
  • Major depression or non-stabilized psychiatric disorder
  • Drug or alcohol abuse
  • Previous palatal or tongue surgery
  • Stable or unstable angina
  • congestive heart failure (CHF)
  • moderate or severe valvular disease
  • transient ischemic attack (TIA)/cardiovascular accident (CVA)
  • Carotid stenosis or endarterectomy
  • Room air oxygen saturation (SpO2) < 95%
  • Pulmonary hypertension
  • Central or mixed apnea ≥ 10% of respiratory events
  • Participation in another clinical study (enrolled in any concurrent study) whose investigational plan is judged to interfere or affect any of the measures of this study

结局指标

主要结局

Mean Apnea Hypopnea Index (AHI) at 6 Months Post-baseline

时间窗: 6 months following last treatment

The primary endpoint is the apnea hypopnea index (AHI) at 6 months post-baseline.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (11)

Loading locations...

相似试验

Radiofrequency Ablation for Multi-level Obstructive... | 临床试验